GCLC and head and neck cancer: For instance, MYH9 facilitates the cell EMT and migration of colorectal cancer by activating MAPK/AKT signalling [46], and promotes cell invasion and radioresistance in head and neck cancer by modulating the cellular ROS levels via activation of the MAPK/Nrf2/GCLC axis [47].